Fibrogenic signals persist in DAA-treated HCV patients after sustained virological response.
Montaldo C, Terri M, Riccioni V, Battistelli C, Bordoni V, D'Offizi G, Prado MG, Trionfetti F, Vescovo T, Tartaglia E, Strippoli R, Agrati C, Tripodi M.
Montaldo C, et al. Among authors: bordoni v.
J Hepatol. 2021 Dec;75(6):1301-1311. doi: 10.1016/j.jhep.2021.07.003. Epub 2021 Jul 13.
J Hepatol. 2021.
PMID: 34271004
Free article.